|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 291.20 DKK | -5.13% |
|
-7.83% | -53.35% |
| 09:50pm | Metsera says Pfizer to buy Metsera for up to $86.25 per share | RE |
| 08:29pm | Pfizer sweetens its offer for Metsera in bidding war against Novo - Bloomberg news | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVO NORDISK A/S | Other Pharmaceuticals | -5.13% | -7.83% | -53.35% | -60.11% | +30.77% | 211B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition